Hyperplasmocytose réactionnelle et syndrome inflammatoire : l’apport décisif de la TEP-TDM

Médecine Nucléaire 2026

View at publisher

Authors: Imen Mhiri, Fatma Chaltout, K. Ben Ahmed, Issam Jardak, S. Charfeddine

DOI: 10.1016/j.mednuc.2026.01.161

Cited by: 0

Fields of Study & Subjects

Vasculitis and related conditions Hematological disorders and diagnostics Multiple Myeloma Research and Treatments